Physician profile
Kurtis E Moyer
NPI 1174780811
$4,717.55
in general payments reported to CMS, 2019-2025
10 companies · $795 in 2025
The $795 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $221 · 2020: $2,017 · 2021: $364 · 2022: $381 · 2023: $361 · 2024: $578 · 2025: $795.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,735.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,734.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $2,749.73 | 2019-2025 | |
| Mentor Worldwide LLC | $749.38 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Medtronic, INC. | $206.12 | 2021-2025 | Plasmablade(Tm) |
| Depuy Synthes Sales INC. | $192.68 | 2022-2023 | Trumatch, Xcm Biologic Tissue Matrix |
| Davol INC. | $149.35 | 2023 | Phasix Mesh |
| Abbvie INC. | $145.38 | 2025 | |
| Tela Bio, INC. | $143.63 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Polynovo North America LLC | $139.74 | 2025 | Novosorb Btm |
| Pacira Pharmaceuticals Incorporated | $124.25 | 2024 | Exparel |
| Checkpoint Surgical, INC | $117.29 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kurtis Moyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.